Becton Dickinson and Co (NYSE:BDX)
| 258.57 Delayed Data As of Sep 29 |  -4.17 / -1.59%Today’s Change | 215.90 Today|||52-Week Range 287.32 | +1.68% Year-to-Date |
Latest BDX News | Press Releases
| Here's Why You Should Hold BD (BDX) Stock in Your Portfolio Sep 19 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 262.74 |
| Today’s open | 262.37 |
| Day’s range | 257.89 - 262.37 |
| Volume | 1,244,039 |
| Average volume (3 months) | 1,222,881 |
| Market cap | $75.0B |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -14.37% |
| Earnings growth (this year) | +7.62% |
| Earnings growth (next 5 years) | +9.36% |
| Revenue growth (last year) | -6.81% |
| P/E ratio | 46.8 |
| Price/Sales | 3.39 |
| Price/Book | 2.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | -0.57 | -1.07% |
| DXCMDexcom Inc | -2.14 | -2.24% |
| WSTWest Pharmaceutical ... | -3.86 | -1.02% |
| ZBHZimmer Biomet Holdin... | -0.20 | -0.18% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | $3.47 |
| Annual revenue (last year) | $18.9B |
| Annual profit (last year) | $1.8B |
| Net profit margin | 8.66% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Franklin Lakes, New Jersey |
Forecasts
